Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

322
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
322
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

721
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
721
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.6K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.6K
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

77
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
77
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

111
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
111
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

87
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
87

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pituitary Metastasis in Lung Cancer Patients: Case Series and Review of the Literature.

Current oncology (Toronto, Ont.)·2026
Same author

Metabolic aspects of polycystic ovary syndrome.

Expert review of endocrinology & metabolism·2026
Same author

Maternal and neonatal vitamin D metabolite profiling and its long-term impact on childhood growth: findings from the KLOTHO birth cohort.

Frontiers in endocrinology·2026
Same author

Endocrine care of transgender and gender-diverse adults: Swiss recommendations.

Swiss medical weekly·2026
Same author

Erectile dysfunction and antihypertensive therapy: A critical reappraisal.

European journal of internal medicine·2026
Same author

Serum-Soluble Receptor for Advanced Glycation End Products as a Potential Biomarker in Lung Cancer Patients.

Journal of personalized medicine·2026
Same journal

Resmetirom and semaglutide therapy for patients with MAFLD in the MENA region: expert panel recommendations.

Expert review of endocrinology & metabolism·2026
Same journal

The relationship between iron deficiency and thyroid function: findings from a population-based study in Jordan.

Expert review of endocrinology & metabolism·2026
Same journal

Beyond normalization: rethinking optimal prolactin levels in prolactinoma management.

Expert review of endocrinology & metabolism·2026
Same journal

Surgical considerations for adult Graves' disease: a narrative review of indications, perioperative challenges and postoperative outcomes.

Expert review of endocrinology & metabolism·2026
Same journal

Is metformin therapy limiting the benefits of exercise?

Expert review of endocrinology & metabolism·2026
Same journal

What is the role of amylin as an emerging therapeutic agent in obesity?

Expert review of endocrinology & metabolism·2026
See all related articles

Related Experiment Video

Updated: Nov 23, 2025

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome
04:49

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome

Published on: July 5, 2024

1.4K

Tailoring treatment for PCOS phenotypes.

Georgios Papadakis1, Eleni A Kandaraki2,3, Anna Garidou4

  • 1Endocrinology and Diabetes, STEPS Stoffwechselzentrum , Biel/Bienne, Switzerland.

Expert Review of Endocrinology & Metabolism
|December 31, 2020
PubMed
Summary
This summary is machine-generated.

Polycystic ovary syndrome (PCOS) management targets specific phenotypes, including metabolic, hyperandrogenic, and reproductive symptoms. Personalized treatment plans, considering factors like anti-Müllerian hormone and gut microbiome, are crucial for effective PCOS care.

Keywords:
Anovulationhyperandrogenisminsulin resistanceobesity phenotypes of PCOSpolycystic ovary syndrome

More Related Videos

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
09:44

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model

Published on: March 5, 2022

3.2K
A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
08:20

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Published on: October 2, 2018

11.6K

Related Experiment Videos

Last Updated: Nov 23, 2025

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome
04:49

Author Spotlight: Investigating the Mechanisms and Inducing Models of Polycystic Ovary Syndrome

Published on: July 5, 2024

1.4K
Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
09:44

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model

Published on: March 5, 2022

3.2K
A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
08:20

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Published on: October 2, 2018

11.6K

Area of Science:

  • Reproductive Endocrinology
  • Metabolic Disorders

Background:

  • Polycystic ovary syndrome (PCOS) is a common endocrinopathy in women of reproductive age.
  • Key features include hyperandrogenism, polycystic ovaries, chronic anovulation, and metabolic issues.
  • Treatment strategies are tailored to the distinct phenotypes of PCOS.

Purpose of the Study:

  • To review current management strategies for different PCOS phenotypes.
  • To highlight emerging biomarkers and their relation to PCOS severity.
  • To discuss the evolving nature of PCOS phenotypes and individualized treatment approaches.

Main Methods:

  • Review of management strategies for metabolic, hyperandrogenic, and reproductive phenotypes.
  • Inclusion of lifestyle modifications, pharmacotherapy, cosmetic procedures, and alternative treatments.
  • Consideration of new research on anti-Müllerian hormone, gut microbiome, and metabolomics.

Main Results:

  • Metabolic phenotype management involves lifestyle changes and insulin-sensitizers.
  • Hyperandrogenic phenotype treatment includes cosmetic procedures and hormonal therapies.
  • Reproductive phenotype management utilizes ovulation induction agents and lifestyle adjustments.
  • Alternative therapies like dietary supplements and acupuncture are also discussed.

Conclusions:

  • Emerging parameters like AMH, gut microbiome, and metabolomics correlate with severe PCOS phenotypes.
  • PCOS phenotypes can change over time and coexist within individuals.
  • Individualized treatment is key, but phenotypical grouping may also be clinically beneficial.